TITLE

CORRECTIONS

PUB. DATE
October 2005
SOURCE
Gut;Oct2005, Vol. 54 Issue 10, p1508
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction Notice
ABSTRACT
Presents several corrections to articles published in previous issues of this journal. Correction to an article published in the August issue; Report that the article discusses the impact on disease outcome in individuals with hepatitis C infection from a single source; Correction to another article discussing randomised controlled trial comparing percutaneous radio frequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma.
ACCESSION #
18457717

 

Related Articles

  • Hepatitis A, B, G cases drop dramatically over 10 years.  // East Bernard Express (TX);3/22/2007, Vol. 64 Issue 12, p5 

    The article reports that Hepatitis A, B, C cases in the U.S. drop dramatically over 10 years, between 1995 and 2005, according to the Center for Disease Control and Prevention.

  • Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil.  // Journal of Antimicrobial Chemotherapy (JAC);May2007, Vol. 59 Issue 5, p827 

    Most chronic hepatitis B patients do not undergo a curative response to interferon-α or nucleoside/nucleotide-based regimens and require long-term therapy. Long-term safety, efficacy and resistance profiles of hepatitis B virus (HBV) drugs are therefore crucial issues for patient management....

  • Non-A, Non-B Hepatitis: Sorting through a Diagnosis of Exclusion. Alter, Miriam J. // Annals of Internal Medicine;4/15/89, Vol. 110 Issue 8, p583 

    Editorial. Discusses the consideration of non-A, non-B hepatitis by a diagnosis of exclusion since the development of diagnostic tests for hepatitis B virus and its elimination as a major cause of transfusion-associated hepatitis. Types of non-A, non-B hepatitis which are probably causes by...

  • Hepatitis C Basics. Sitzman, Kathy // AAOHN Journal;Mar2004, Vol. 52 Issue 3, p132 

    Presents information on Hepatitis C. Prevalence of Hepatitis C in the U.S.; People who are at risk of Hepatitis C; Percentage of individuals infected with the disease who have no known risk factors.

  • Acute Brucella Hepatitis in an Urban Patient. Zadeh, Mina Asef; Allami, Abbas; Alavian, Seyed Moayed // Hepatitis Monthly;Autumn2009, Vol. 9 Issue 4, p310 

    A 35-year-old man was referred to our center because of low grade fever, vomiting, yellow sclera, and tenderness in the upper-right quadrant of his abdomen. Laboratory tests showed a white blood cell (WBC) of 7100/μL, a platelet of 184,000/μ1, an erythrocyte sedimentation rate (ESR) of 4...

  • Non-Travel-Associated Hepatitis E in England and Wales: Demographic, Clinical, and Molecular Epidemiological Characteristics. Ijaz, Samreen; Arnold, Eve; Banks, Malcolm; Bendall, Richard P.; Cramp, Matthew E.; Cunningham, Richard; Dalton, Harry R.; Harrison, Tim J.; Hill, Simon F.; MacFarlane, Lorna; Meigh, Rolf E.; Shafi, Shuja; Sheppard, Martin J.; Smithson, Jacquie; Wilson, Melanie P.; Chong-Gee Teo // Journal of Infectious Diseases;10/1/2005, Vol. 192 Issue 7, p1166 

    Between 1996 and 2003, 186 cases of hepatitis E were serologically diagnosed. Of these, 17 (9%) were not associated with recent travel abroad. Patients were 155 years old (range, 56-82 years old) and tended to be male (76%). Two patients presented with fulminant hepatitis. A total of 129 (69%)...

  • Phylogenetic analysis and subtyping of acute and fulminant strains of hepatitis E virus isolates of North India with reference to disease severity. Pujhari, Sujit Kumar; Kumar, Subrat; Ratho, Radha Kanta; Chawla, Yogesh Kumar; Chakraborti, Anuradha // Archives of Virology;Sep2010, Vol. 155 Issue 9, p1483 

    Hepatitis E is endemic to the Indian subcontinent, with a seroprevalence of 4-20%, and more than 25% of acute viral hepatitis is due to HEV. The northern parts of India have been experiencing outbreaks and sporadic cases of HEV since 1955. In a total of sixteen HEV sequences, ten acute viral...

  • Fighting Fire With Fire: Effects of Oncolytic Virotherapy on Underlying Viral Hepatitis in Hepatocellular Carcinoma. Reid, Tony // Molecular Therapy;Sep2008, Vol. 16 Issue 9, p1521 

    The article offers information on the effects of oncolytic virotherapy on underlying viral hepatitis in hepatocellular carcinoma (HCC). It states that HCC is considered as the fifth most common cancer in the world and the third most common reason of cancer-related deaths. Moreover, it is posed...

  • Meetings.  // World Journal of Gastroenterology;3/28/2009, Vol. 15 Issue 12, p1533 

    A calendar of events related to gastroenterology to be held in 2009 is presented which includes the 13th International Symposium on Viral Hepatitis and Liver Disease in Washington, D.C., the British Society of Gastroenterology (BSG) Annual Meeting in Scotland and the 44th Annual Meeting of the...

  • Autochthonous hepatitis E in southwest England. Barton, Anna L. // Annals of Clinical Biochemistry;Sep2008, Vol. 45 Issue 5, p534 

    The article cites a research study led by H.R. Dalton and colleagues on autochthonous hepatitis E in southwest England that was published in the "Journal of Viral Hepatitis." Dalton et al. identified hepatitis E cases by testing of blood samples from patients with unexplained hepatic illness. A...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics